Experiments for taxon Fasciospongia cavernosa (SPONGIIDAE)

62 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
243762	ISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
243759	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE F
218706	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE D
243761	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE F
1051923	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	CAVERNOSINE
128421	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	FASCIOSPONGIA TERPENE 2
184771	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B
215874	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CAVERNOSOLIDE
839364	PRESENT IN (REVIEW)		Fasciospongia cavernosa (SPONGIIDAE)	ALANINE METHYL ESTER,BETA: N-ACYL-2-METHYLENE:
229837	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	ALANINE,BETA: N-ACYL-2-METHYLENE: METHYL ESTER 1
220301	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
220293	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
229836	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	ALANINE,BETA: N-ACYL-2-METHYLENE: METHYL ESTER 3
243758	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIBACTERIAL ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE F
181575	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE C
166462	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CHOLESTA-4-6-8(14)-TRANS-22-TETRAEN-3-ONE
184775	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B
220299	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
282067	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	HEXADECA-1-3(5)-4(R)-TRIOL,2'(R)-HYDROXY-PENTACOSYL-AMIDE: 2(S):
220298	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
184770	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B
128420	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	FASCIOSPONGIA TERPENE 1
243763	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
220304	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
184773	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B
244735	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE FCACOSPONGIONOLIDE B
215873	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CAVERNOSOLIDE
243760	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE F
181574	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B,25-DEOXY:
220300	ISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
220306	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
166461	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	FASCIOSPONGIA TRISNORDITERPENE
229908	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
220297	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
184774	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B
220292	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
243766	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
218707	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	LUFFARIN V,CIS-6:
181573	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B,25-DEOXY:
218704	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	LUFFARIN V,CIS-6:
220295	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
218702	VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
220303	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
128423	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	FUROSPONGIN 1,12-13-DIDEHYDRO: (-):
220296	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
243764	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
184772	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B
220305	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
229907	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	GLACIASTEROL B 3-ACETATE
243767	PHARMACOLOGY OF COMPOUND - IN VITRO	FISH POISON	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
218703	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE D
215875	PHARMACOLOGY OF COMPOUND - IN VITRO	TOXIC EFFECT(GENERAL)	Fasciospongia cavernosa (SPONGIIDAE)	CAVERNOSOLIDE
181572	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B,25-DEOXY:
218705	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE D
243765	ISOLATION AND IDENTIFICATION OF		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
128422	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Fasciospongia cavernosa (SPONGIIDAE)	FASCIOSPONGIA TERPENE 3
220291	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
244736	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	FASCIOSPONGIA COMPOUND 3
243757	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE F
220302	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE B
220294	PHARMACOLOGY OF COMPOUND - IN VITRO	PHOSPHOLIPASE A2 INHIBITION	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONGIONOLIDE E
184776	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Fasciospongia cavernosa (SPONGIIDAE)	CACOSPONNGIONOLIDE B

Experiments for taxon Fasciospongia cavernosa (SPONGIIDAE)

Experiments (62 results)

Filters

Worktypes (14)

Pharmacology (8)

Compounds (22)

Organisms (14)